Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Business

Brokerages Recommend Ashok Leyland, Affle 3i, Concord Biotech for Short-Term Gains

· · 3 min read

SMC Global Securities and Canara Bank Securities have identified Ashok Leyland, Affle 3i, Concord Biotech, and Sundram Fasteners as top short-term stock picks. These recommendations are based on strong technical indicators and potential for bullish breakouts in the Indian equity markets.

Amidst a period of recovery in the Indian equity markets, leading domestic brokerage firms SMC Global Securities and Canara Bank Securities have issued fresh recommendations for several stocks, highlighting their potential for short-term gains. The firms have based their selections on robust technical chart patterns and favorable market parameters, suggesting these stocks are poised for upward movement.

Top Short-Term Stock Recommendations

Investors looking for opportunities in the current market climate may consider the following picks, which come with specific target prices and stop-loss levels.

Ashok Leyland Ltd.

Recommended by SMC Global Securities, Ashok Leyland is currently observed trading within a symmetrical triangle pattern on its daily chart. The stock appears to be on the cusp of a bullish breakout following a prolonged period of consolidation. It has consistently formed higher lows, while a falling trend line has previously capped upward attempts, indicating a gradual accumulation of buying momentum. Recent movement above the upper trend line, supported by an improving Relative Strength Index (RSI) and a positive Moving Average Convergence Divergence (MACD) crossover, points to strengthening bullish sentiment. The immediate resistance was around Rs 164-166, which the stock is now overcoming, with support near Rs 155-157. A sustained close above Rs 166 could confirm the breakout, paving the way for further advances.

  • Recommendation: Buy
  • Target Price: Rs 182-185
  • Stop Loss: Rs 152

Affle 3i (Affle India Ltd.)

Canara Bank Securities has identified Affle 3i for its short-term potential. The stock's chart demonstrates a bullish breakout from a significant long-term downward trendline. Its price has moved above all key moving averages, signaling improved momentum and a strengthening trend structure. The RSI is currently in a bullish zone around 57, reflecting solid momentum with ample room before reaching overbought territory, suggesting further upside without immediate exhaustion.

  • Recommendation: Buy at current market price (around Rs 1,609.3)
  • Target Price: Rs 1,723.90-1,794.20
  • Stop Loss: Rs 1,535

Concord Biotech Ltd.

SMC Global Securities also recommends Concord Biotech, which is exhibiting an ascending triangle formation on its daily chart. This pattern indicates sustained accumulation after a strong recovery from previous lows. The stock has been establishing higher lows while repeatedly testing horizontal resistance near Rs 1,390-1,410, signaling increasing buying pressure. A recent breakout above its consolidation range, bolstered by an improving RSI and a positive MACD crossover, suggests strengthening bullish momentum. The rising trend line offers support around Rs 1,270-1,290, expected to act as immediate support on any pullback, with the Rs 1,390-1,410 zone now becoming key breakout support. A sustained close above Rs 1,410 could extend the upward movement.

  • Recommendation: Buy
  • Target Price: Rs 1,540-1,550
  • Stop Loss: Rs 1,275

Sundram Fasteners Ltd.

Canara Bank Securities has also highlighted Sundram Fasteners. The stock's chart shows a bullish breakout from a long-term downward trendline, with its price moving above most of its moving averages, indicating improving momentum and a robust trend structure. The RSI is positioned around 64, within the bullish zone, signifying firm momentum and room for further appreciation before reaching overbought levels.

  • Recommendation: Buy at current market price (around Rs 969.25)
  • Target Price: Rs 1,040.80-1,134
  • Stop Loss: Rs 905.35

Disclaimer: This information is for educational purposes only and should not be considered investment advice. Readers should consult a qualified financial advisor before making any investment decisions.

Related